BlueCrest Capital Management’s Silicon Laboratories SLAB Stock Holding History

BlueCrest Capital Management’s Portfolio SLAB Stock Details SLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,075	Closed	-$249K	–	958
2019 Q1	$249K	Buy	+3,075	New	+$256K	0.01%	809
2018 Q2	–	Sell	-2,722	Closed	-$245K	–	1789
2018 Q1	$245K	Buy	+2,722	New	+$257K	0.01%	1181

Other funds holding SLAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlueCrest Capital Management's SLAB Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Silicon Laboratories (SLAB) in Q2 2019, closing a stake of 3,075 shares — an estimated $249K sold.

BlueCrest Capital Management first reported a position in SLAB in Q1 2018 and held it in 2 quarters. The position peaked at $249K in Q1 2019. 259 funds tracked by Wall St. Rank hold SLAB as of Q2 2019.

BlueCrest Capital Management reported no remaining Silicon Laboratories position as of Q2 2019 after selling out during the quarter.
BlueCrest Capital Management sold 3,075 Silicon Laboratories shares in Q2 2019, an estimated $249K.
BlueCrest Capital Management first reported a position in Silicon Laboratories in Q1 2018 and held it in 2 quarters.
BlueCrest Capital Management's Silicon Laboratories position peaked at $249K in Q1 2019.
259 funds tracked by Wall St. Rank held Silicon Laboratories as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.